More News

07 Dec 2017 XOMA Announces Exclusive License Agreement for XOMA 358 with Rezolute, Inc.
07 Dec 2017 Carmot Enters a Multi-Year Drug Discovery Collaboration With Amgen
07 Dec 2017 BioInvent and Transgene collaborate on next generation oncolytic viruses encoding an anti-CTLA-4 antibody to treat solid tumors
06 Dec 2017 Ayala Pharmaceuticals, Founded by Israel Biotech Fund, aMoon and Harel Insurance, Enters Exclusive Worldwide License Agreement with Bristol-Myers Squibb (BMS) to Develop Cancer Treatments
06 Dec 2017 TetraGenetics and ModiQuest Collaborating for the Discovery of Therapeutic Antibodies Against KCa3.1
06 Dec 2017 Juno Therapeutics Signs Licensing Agreements with Lilly, OncoTracker, and Fred Hutchinson Cancer Research Center to Advance Its BCMA-Directed Engineered T Cell Program in Multiple Myeloma with Gamma Secretase Inhibition
06 Dec 2017 Obsidian Therapeutics Announces $49.5 Million Series A Financing to Develop Controllable Cell and Gene Therapy Products
05 Dec 2017 CSL and Vitaeris Announce Strategic Partnership with Option to Acquire
05 Dec 2017 Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding
04 Dec 2017 Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel Deaconess Medical Center, to Develop CRISPR/Cas9-Enhanced CAR T Therapies
04 Dec 2017 Takeda announces research collaboration in ALS with Montreal Neurological Institute
04 Dec 2017 FDA Approves Amgen's Repatha® (evolocumab) To Prevent Heart Attack And Stroke
01 Dec 2017 Astellas Acquires Mitobridge Under Existing Collaboration
30 Nov 2017 MorphoSys Signs Regional License Agreement for Antibody MOR202 with I-Mab
29 Nov 2017 Regeneron and Decibel Therapeutics Announce Strategic Collaboration to Discover and Develop Therapeutics for Hearing Loss and Tinnitus
29 Nov 2017 Melinta Therapeutics Enters Into Agreement to Acquire Infectious Disease Business from The Medicines Company
28 Nov 2017 X-Chem and Gilead Announce Drug Discovery Collaboration
28 Nov 2017 PhaseBio Enters Worldwide License Agreement with MedImmune for a Reversal Agent for Ticagrelor
28 Nov 2017 Cytovance Biologics, Inc. announces Bexion Pharmaceuticals Inc. has chosen Cytovance to manufacture the protein component and active ingredient of Bexion’s first clinical compound, BXQ-350
27 Nov 2017 HITGEN and Boehringer Ingelheim Enter DNA-Encoded Library Based Drug Discovery Research Collaboration
27 Nov 2017 Medeor Therapeutics Raises $57 Million In Series B Financing
27 Nov 2017 Biogen and Alkermes Announce License and Collaboration Agreement to Develop and Commercialize ALKS 8700 for the Treatment of Multiple Sclerosis
27 Nov 2017 Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B
21 Nov 2017 Step Pharma Completes €14.5 million Series A Financing with Additional New Investor
21 Nov 2017 Immunovaccine and Leidos Expand Collaboration to Develop Malaria Vaccines Formulated in DepoVax™

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top